305 results on '"Gazzaniga P"'
Search Results
2. Small and Disadvantaged Business Enterprise (SB/DBE) Issues in Caltrans Contract and Bid Process
3. Correction to: The Montreal Cognitive Assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy
4. Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy
5. Gut microbial fatty acid isomerization modulates intraepithelial T cells
6. Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
7. Complications of unintentional dural puncture during labour epidural analgesia: a 10-year retrospective observational study
8. Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy
9. Personal Identity and Online Communities
10. The Montreal Cognitive Assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy
11. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
12. Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
13. Harm to self outweighs benefit to others in moral decision making
14. Correction to: The Montreal Cognitive Assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy
15. The Posteromedial Region of the Default Mode Network Shows Attenuated Task-Induced Deactivation in Psychopathic Prisoners
16. Divergent hemispheric reasoning strategies: reducing uncertainty versus resolving inconsistency
17. An Investigation of the Effects of the Core Protein Telomerase Reverse Transcriptase on Wnt Signaling in Breast Cancer Cells
18. The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
19. Reply to the “Letter to the Editors” by Steven Buyske
20. The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC)
21. Symposium: What is Cognitive Neuroscience?
22. 127P RAS, RAF and NF1 oncogenic mutations in KRAS-mutated lung adenocarcinoma
23. 1777P 13 genes panel validation to assess minimal residual disease through urinary tumor DNA in muscle-invasive bladder cancer patients
24. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis
25. Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
26. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
27. Aristotle - Ἀριστοτέλης (ARISTOTÉLĒS, 384/3- 322/1 BCE) The revelation of tuberculosis in his zoological works
28. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
29. Environmentally determined juvenile growth rates dictate the degree of sexual size dimorphism in the Sardinian brook newt
30. The Use of Biologics in NFL Athletes: An Expert Consensus of NFL Team Physicians.
31. Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?
32. 3MO Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
33. 1252P Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)
34. A Novel Injection-Molded Capsular Device for Oral Pulsatile Delivery Based on Swellable/Erodible Polymers
35. Fatal Chytridiomycosis in the Tyrrhenian Painted Frog
36. The Use of ß-Cyclodextrin in the Manufacturing of Disintegrating Pellets with Improved Dissolution Performances
37. Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindings
38. Non-canonical roles for telomerase in T cells and breast cancer cells
39. Isolation and molecular characterization of a mouse renal microvascular endothelial cell line
40. Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero
41. Impact of EGFR expression on colorectal cancer patient prognosis and survival: a response
42. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer
43. Expression and prognostic significance of LIVIN, SURVIVINand other apoptosis-related genes in the progression of superficial bladder cancer
44. Detecting the disappearance of RAS-mutant clones in the plasma of patients with RAS-mutant mCRC to select patient candidates for anti-EGFR treatment and to monitor resistance to treatment
45. EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer
46. Circulating tumor cells in young and elderly patients with colorectal cancer: “lupus et agnus”
47. Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders
48. Clinical utility of circulating tumor cell counting through CellSearch®: the dilemma of a concept suspended in Limbo
49. EPAC-Lung
50. Second line EGFR-inhibitors in RAS mutant metastatic colorectal cancer: The plasma RAS wild type “window of opportunity”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.